Pandemic response and preparedness has presented significant health, economic and social challenges. In the wake of the COVID-19 pandemic and the need for greater investment in therapeutics development, it’s clear that existing commercial and academic funding models will not deliver the required platforms.
The Cumming Global Centre for Pandemic Therapeutics will become the world’s pre-eminent medical research Centre focused on therapeutic development for future pandemics with a unique approach.
-
The power of therapeutics
In the inevitable event of the next pandemic, therapeutics will help to reduce the progression of infection to disease, reduce disease severity and reduce transmission of infection and fill the gap if a vaccine is unavailable.
-
Platform focus
It’s difficult to identify the pathogen that will cause the next pandemic. No-one predicted SARS-CoV-2, so it’s critical that we are prepared for threats both known and unknown.
-
Mission-driven approach
We adopt a mission-driven approach through long-term funding, global connectivity and adopting a higher risk tolerance than most.
-
Strategic location
The Cumming Global Centre for Pandemic Therapeutics was established in Melbourne’s biomedical precinct in recognition of the state of Victoria’s global standing as a leader in biomedical research and learning.
-
Global reach
We take a partnership approach to attract global research expertise from diverse disciplines, driving long-term impact.